Anita Sung

1.0k total citations
29 papers, 718 citations indexed

About

Anita Sung is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Anita Sung has authored 29 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in Anita Sung's work include Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (8 papers) and Antibiotic Use and Resistance (4 papers). Anita Sung is often cited by papers focused on Antifungal resistance and susceptibility (15 papers), Fungal Infections and Studies (8 papers) and Antibiotic Use and Resistance (4 papers). Anita Sung collaborates with scholars based in United States, United Kingdom and France. Anita Sung's co-authors include Reinhard Horvat, Jan E. Schnitzer, Jerónimo Bravo, Hiroyuki Yoshida, Amnon Altman, Chris Elly, Tomas Mustelin, Yun‐Cai Liu, Nathalie Bonnefoy and Kimishige Ishizaka and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Anita Sung

27 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anita Sung United States 13 285 148 134 130 60 29 718
Robert R. LaBadie United States 21 234 0.8× 211 1.4× 191 1.4× 139 1.1× 87 1.4× 51 1.0k
Miaomiao Li China 17 217 0.8× 118 0.8× 94 0.7× 288 2.2× 62 1.0× 102 1.0k
Marcelo Chen Taiwan 18 238 0.8× 255 1.7× 79 0.6× 164 1.3× 32 0.5× 95 1.1k
Anne Hulin France 21 321 1.1× 180 1.2× 168 1.3× 224 1.7× 129 2.1× 74 1.4k
Andrew Reid United Kingdom 15 289 1.0× 469 3.2× 181 1.4× 199 1.5× 31 0.5× 34 1.1k
M L B Bhatt India 14 263 0.9× 172 1.2× 156 1.2× 54 0.4× 31 0.5× 48 951
Masumi Ueda United States 17 292 1.0× 144 1.0× 442 3.3× 133 1.0× 22 0.4× 87 1.2k
Wenjun Cao China 20 256 0.9× 60 0.4× 147 1.1× 97 0.7× 31 0.5× 70 1.0k
Yishai Ofran Israel 22 388 1.4× 67 0.5× 259 1.9× 127 1.0× 53 0.9× 98 1.3k
Jill‐Patrice Cassuto France 13 342 1.2× 103 0.7× 80 0.6× 429 3.3× 43 0.7× 21 938

Countries citing papers authored by Anita Sung

Since Specialization
Citations

This map shows the geographic impact of Anita Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anita Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anita Sung more than expected).

Fields of papers citing papers by Anita Sung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anita Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anita Sung. The network helps show where Anita Sung may publish in the future.

Co-authorship network of co-authors of Anita Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Anita Sung. A scholar is included among the top collaborators of Anita Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anita Sung. Anita Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Micallef, Christianne, et al.. (2023). Using Behavior Change Theory to Identify Drivers and Barriers for Antifungal Treatment Decisions: A Case Study in a Large Teaching Hospital in the East of England, UK. Infectious Diseases and Therapy. 12(5). 1393–1414. 1 indexed citations
2.
Chakrabarti, Arunaloke, et al.. (2022). The Role Of Diagnostic Tests in Antifungal Stewardship For Treating Invasive Fungal inFections: A Plain Language Summary. Future Microbiology. 18(1). 9–13. 1 indexed citations
3.
Chakrabarti, Arunaloke, et al.. (2022). The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review. Open Forum Infectious Diseases. 9(7). ofac234–ofac234. 27 indexed citations
4.
5.
Sung, Anita, et al.. (2022). Characterizing patients with rare mucormycosis infections using real-world data. BMC Infectious Diseases. 22(1). 154–154. 3 indexed citations
6.
Sung, Anita, Stéphan Martin, Michael Benigno, et al.. (2021). Patient Characteristics and Risk Factors in Invasive Mold Infections: Comparison from a Systematic Review and Database Analysis. ClinicoEconomics and Outcomes Research. Volume 13. 593–602. 4 indexed citations
7.
Fusco, Manuela Di, Kimberly M. Shea, Jay Lin, et al.. (2021). Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. Journal of Medical Economics. 24(1). 308–317. 135 indexed citations
8.
9.
McCann, Eilish, et al.. (2020). <p>Contributing Factors to the Clinical and Economic Burden of Patients with Laboratory-Confirmed Carbapenem-Nonsusceptible Gram-Negative Urinary Tract Infections</p>. ClinicoEconomics and Outcomes Research. Volume 12. 191–200. 20 indexed citations
10.
Tabak, Ying P., et al.. (2020). Attributable burden in patients with carbapenem-nonsusceptible gram-negative respiratory infections. PLoS ONE. 15(2). e0229393–e0229393. 11 indexed citations
11.
12.
Gundrum, Jake, et al.. (2018). Health-care utilization and outcomes of patients at high risk of invasive fungal infection. ClinicoEconomics and Outcomes Research. Volume 10. 371–387. 4 indexed citations
13.
14.
15.
Tabak, Ying P., Anita Sung, Richard S. Johannes, et al.. (2017). Attributable Clinical and Economic Burden of Carbapenem Non-Susceptible Gram-Negative Infections among Patients Hospitalized with Respiratory Infections. Open Forum Infectious Diseases. 4(suppl_1). S147–S147. 1 indexed citations
16.
Sung, Anita, et al.. (2015). Inconsistency in Defining Profound and Prolonged Neutropenia for Antifungal Prophylaxis Decisions. 1 indexed citations
17.
Smith, Megan V., et al.. (2012). Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Human Development. 89(2). 81–86. 27 indexed citations
18.
Levin, Jeremy I., Frances C. Nelson, Loran M. Killar, et al.. (2002). Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1′ group. Bioorganic & Medicinal Chemistry Letters. 12(8). 1199–1202. 62 indexed citations
19.
Levin, Jeremy I., Frances C. Nelson, John F. DiJoseph, et al.. (2001). The discovery of anthranilic acid-based mmp inhibitors. Part 3: incorporation of basic amines. Bioorganic & Medicinal Chemistry Letters. 11(22). 2975–2978. 30 indexed citations
20.
Glaser, Keith B., Richard P. Carlson, Anita Sung, et al.. (1993). Pharmacological characterization of WAY-121,520: A potent anti-inflammatory indomethacin-based inhibitor of 5-lipoxygenase (5-LO)/phospholipase A2 (PLA2). Inflammation Research. 39(S1). C30–C32. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert R. LaBadie Breakdown of academic impact, for papers by Miaomiao Li Breakdown of academic impact, for papers by Marcelo Chen Breakdown of academic impact, for papers by Anne Hulin Breakdown of academic impact, for papers by Andrew Reid Breakdown of academic impact, for papers by M L B Bhatt Breakdown of academic impact, for papers by Masumi Ueda Breakdown of academic impact, for papers by Wenjun Cao Breakdown of academic impact, for papers by Yishai Ofran Breakdown of academic impact, for papers by Jill‐Patrice Cassuto
Rankless by CCL
2026